Hazel X. Ang

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Moiez Ali, Min Lu, Hazel X. Ang et al. · Science Translational Medicine · 2022 · 41 citations · Full text

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Kevin Lin, Justine C. Rutter, Abigail Xie et al. · Nature Cancer · 2022 · 38 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule

Loïs Kelly, Justine C. Rutter, Kevin Lin et al. · Nature Cancer · 2024 · 23 citations · Full text

Hematological Malignancy, Heterobifunctional Degrader Molecule, Acute Myeloid Leukemia +8

Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13

Hazel X. Ang, Natalia Sutiman, Xinyue Deng et al. · Proceedings of the National Academy of Sciences · 2023 · 14 citations · Full text

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i> -Mutant Gastric Cancer

Lyla J. Stanland, Hazel X. Ang, Jacob P. Hoj et al. · Molecular Cancer Research · 2023 · 11 citations · Full text